Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppression optimization in renal transplantation
NCT02444429Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2015
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in renal allograft rejection, sponsored by Hospices Civils de Lyon. Started Sep 2015; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
renal allograft rejection
Beyond the preview
Go deeper on NCT02444429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444429.